March 9 - 10, 2026 - Seoul
BioCentury and BayHelix will bring the 4th East-West Biopharma Summit back to Singapore in March 2025, working with local leaders.
Singapore's government has invested in science, talent, and infrastructure for over 20 years, attracting top investors and opening new doors for partnerships and investment. As a gateway to Asia, Singapore connects industry leaders from an emerging Arc of Innovation, including Japan, Korea, China, Australia, India, and Southeast Asia. Join us for C-level networking, partnering and debate with peers from the East and West.
April 20 - 21, 2026 - Tokyo
Jointly organized between JAPhMed, PhRMA Japan and MAPS, the Japan Medical Affairs Summit has become the most influential annual gathering for Japan’s medical affairs professionals. New regulatory compliance directives continue to challenge the traditional commercial-driven business environment in Japan and a main goal of the Summit is to help break down the barriers between medical and commercial departments. The conference draws attendees from all levels- not only from the medical department, but also from other internal stakeholders including R&D, commercial and policy departments.
May 27 - 28, 2026 - Boston / Cambridge
The Asia Clinical Acceleration Summit brings together senior biotech leaders, life science investors, and CRO partners to explore how Asia's fast and flexible clinical trial ecosystem can unlock earlier data, de-risk development programs, and strengthen company valuations.
Across 1.5 focused days in Cambridge/Boston, attendees will gain practical insights on IND vs. IIT pathways, site and CRO selection, regulatory strategy, and how Asia-enabled clinical data can support U.S. and global filings — plus direct investor perspectives on how Asia data influences diligence and deal timing. The summit also features dedicated networking sessions and an evening reception designed to facilitate meaningful connections among executives navigating similar strategic decisions.
April 15, 2025 - Seoul
AbbVie is seeking to explore exciting new cross-border licensing opportunities with innovative biotechs in Japan.
This event provides an opportunity to meet with senior research and partnership leadership teams to learn about AbbVie’s partnering strategies and interests.
If you feel your company may be a good fit for potential partnership consideration and would like to share information about your pipeline and discovery platforms, you may apply to meet with senior R&D and Corporate Strategy executives from AbbVie to discuss your ideas and research in an in-person one-on-one setting.
October 28 - 30, 2026 - Shanghai
Since its inception in 2008, the ChinaTrials Summit has been a cornerstone for the global clinical development industry to come together and discuss the latest trends and challenges in global clinical development.
Join us for this exciting new chapter of the ChinaTrials Summit as we delve deep into China’s growing role in the global R&D innovation ecosystem.
This year’s Summit will bring together global biopharma R&D perspectives with a special focus on the Asia Region (Japan, Korea, Australia, Singapore)- anchored in clinical development topics that have defined ChinaTrials from the very beginning.
November 2 - 4, 2026 - Shanghai
For over a decade, the China Healthcare Summit has been the destination for biopharma leaders from Asia and the West to network, partner, and debate critical issues facing the industry.
At the 12th China Healthcare Summit, we will discuss how to reinvent your strategy. If you are a China biotech, it is time to reinvent your global strategy. If you are a global biopharma or investor, you must reinvent your China strategy.
Join BioCentury, BayHelix and Insights Partner McKinsey & Company in Shanghai for two days of networking, partnering and debate.
